Amgen received an analyst upgrade today. The biotech giant moved up to a higher rating with the consensus target price now at $353. Short interest stands at just 2.5% of free float. That's a vote of confidence in a $179 billion company navigating patent pressure.
CDW took a harder hit. Barclays analyst Tim Long cut the IT solutions firm's target price from $144 to $123 — a $21 drop. Long maintained a Hold rating. The cut comes amid softer enterprise IT spending trends. CDW's market cap sits at $14 billion.
Coherent Corp. saw its consensus target price jump to $366 from $331 after a recommendation update. The photonics and laser components maker has benefited from AI data centre demand. Analysts are getting more bullish despite a 4.9% short interest reading.
Walt Disney also saw target prices nudge higher to $130. Analysts cited improving streaming margins and resilient park attendance.
Amazon posted the biggest absolute target increase. The consensus average target rose to $312. All 62 active recommendations remain Buys. No analyst covers Amazon with a Sell.
Energy names including Devon Energy and Coterra Energy saw recommendations removed, thinning coverage as oil prices stay under pressure.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
